Releases
28359 items
Releases
US Car Buyers Pivot as New Vehicle Prices Hit Record $52,016
Releases
Luma Health Debuts AI Tool to Bridge Gap Between Ad Spend and Patient Care
Releases
Corporate AI Ambitions Clash With Stagnant Business Results
Releases
ITE Management Scales Intermodal Fleet With NACPC Acquisition
Releases
Verismo Therapeutics adds CLDN6 targeting to KIR-CAR oncology pipeline
Releases
New Center for Therapeutic Genetics Targets Rare Disease at Scale
Releases
Pedego Launches 2.0 Lineup With Two Performance-Focused E-Bikes
Releases
Sumsub Pivots to AI Trust Infrastructure to Consolidate Compliance
Releases
Surgical Planning Associates Opens HipInsight Platform to All Implants
Releases
Broadridge Financial Solutions Sets August 4 Date for Fiscal Year Results
Releases
Abra Group Expands Fleet with Order for 45 Embraer E195-E2 Jets
Releases
Global RAN Market Finds Equilibrium After Period of Sharp Decline
Releases
Air India to Shift JFK Operations to New Terminal 6 by 2028
Releases
Eosera gains retail momentum with EAR PAIN MD +PLUS
Releases
Cheryl Matejka Joins The Group Savings Organization Advisory Board
Releases
Native Acquires Frontline Research to Map Africa’s Offline Trade
Releases
CloudFuze Adds Governance Dashboard to Curb Shadow AI Risks
Releases
7-Eleven Discounts Wings and Tenders for July Chicken Holidays
Releases
At Home Launches 2026 Halloween Collection With 1,000 New Items
Releases
Leap CRM and Scope Technologies Automate Roofing Workflows
Releases
Mill Creek Residential Returns as Lead Sponsor for Fore the Build
Releases
The Red Chickz Targets Dallas Market with New Carrollton Location
Releases
Natural Grocers Offers Utah Members Pioneer Day Rewards
Releases
CSTS Launches PremierX Entertainment Brand During World Cup Finale
Releases
Pet Owners Are Canceling Trips Over Lack of Pet-Friendly Lodging
Releases
Ally Financial releases second quarter 2026 performance data
Releases
Garmin Launches Approach Z10 Laser Rangefinder for Golfers
Releases
Structural Adhesives Market Poised for $19.83 Billion Valuation by 2031
Releases
Nektar Therapeutics Launches Phase 3 Trials for Rezpegaldesleukin
Releases